Henry Schein stock slips 2.60% and underperforms competitors
Updated
Updated · MarketWatch · May 6
Henry Schein stock slips 2.60% and underperforms competitors
6 articles · Updated · MarketWatch · May 6
The shares closed at $72.44 on Wednesday as the S&P 500 rose 1.46% to 7,365.12 and the Dow gained 1.24% to 49,910.59.
Henry Schein ended 18.87% below its 52-week high of $89.29, reached on 24 February.
Among peers, Stryker fell 0.99%, IDEXX Laboratories rose 2.89%, and McKesson dropped 7.16%, leaving Henry Schein's performance mixed against competitors.
Why did Henry Schein’s stock fall after the company reported better-than-expected quarterly earnings?
With insiders selling and guidance underwhelming investors, is Henry Schein's stock now a bargain or a value trap?
After cyberattacks hit two major suppliers, is the entire medical distribution industry facing an unpriced risk?